Study of the biological activity of photoactive bipyridyl-Ru(II) complexes containing 1,3,5-triaza-7-phosphaadamantane (PTA)

被引:5
|
作者
del Pino, Jose Manuel Veiga [1 ]
Scalambra, Franco [1 ]
Bermejo-Casadesus, Cristina [2 ]
Massaguer, Anna [2 ]
Garcia-Maroto, Federico [3 ]
Romerosa, Antonio [1 ]
机构
[1] Univ Almeria, Area Quim Inorgan CIESOL, Almeria, Spain
[2] Univ Girona, Dept Biol, Girona, Spain
[3] Univ Almeria, Area BioQuim, Almeria, Spain
关键词
Ruthenium complexes; Anticancer; Photoactivation; Water-soluble complexes; PTA; TRANSITION-METAL-COMPLEXES; ENHANCED CELLULAR UPTAKE; PHOTODYNAMIC THERAPY; RUTHENIUM COMPLEXES; POLYPYRIDINE COMPLEXES; LIGAND; DNA; CANCER; PHOTOSENSITIZERS; COORDINATION;
D O I
10.1016/j.jinorgbio.2023.112291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The water-soluble ruthenium complex cis-[Ru(dcbpyH)(2)(PTAH)(2)]Cl-2 center dot 3H(2)O (1) (dcbpy = 4,4'-dicarboxy-2,2'bipyridine; PTA = 1,3,5-triaza-7-phosphaadamantane) has been synthesized and characterised by NMR, IR spectroscopy, elemental analysis, and single-crystal X-ray diffraction. The optical properties of 1 were studied, including photoactivation under visible light, as well as its biological properties, together with those of the previously published Ru complexes cis-[Ru(bpy)(2)(PTA)(2)]Cl-2 (2), trans-[Ru(bpy)(2)(PTA)(2)](CF3SO3) 2 (3) and cis[Ru(bpy)(2)(H2O)(PTA)](CF3SO3) 2 (4) (bpy = 2,2'-bipyridine). Anticancer activities of the complexes against human lung (A549), cervical (HeLa) and prostate (PC3) carcinoma cells were evaluated under dark conditions and upon photoactivation with visible light. None of the complexes exhibited cytotoxic activity in the absence of light irradiation (IC50 > 100 mu M). However, after photoactivation, the cytotoxicity of complexes 1, 2 and 3 against the three cell lines markedly increased, resulting in IC50 values between 25.3 mu M and 9.3 mu M. Notably, these complexes did not show toxicity against red blood cells. These findings show the potential of complexes 1, 2 and, particularly, 3 for selective and controlled cancer photochemotherapy. The reactivity of the Ru complexes against DNA under UV-Vis irradiation was studied by analysing plasmid mobility. Experimental data shows that 4 unfolds supercoiled DNA (SC DNA) both in the dark and under visible irradiation, while 1 and 3 are only active under light, being 2 inactive in either case. The unfolding activities of complexes 3 and 4 were dependent on the air present in the reaction. The measured intracellular levels of reactive oxygen species (ROS) upon irradiation with complexes 1, 2 and 3 suggest that their mechanism of action is related to oxidative stress.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties
    Battistin, F.
    Scaletti, F.
    Balducci, G.
    Pillozzi, S.
    Arcangeli, A.
    Messori, L.
    Alessio, E.
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2016, 160 : 180 - 188
  • [2] New Findings in Metal Complexes with Antiproliferative Activity Containing 1,3,5-Triaza-7-phosphaadamantane (PTA) and Derivative Ligands
    Scalambra, Franco
    Lorenzo-Luis, Pablo
    de los Rios, Isaac
    Romerosa, Antonio
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2019, (11-12) : 1529 - 1538
  • [3] Synthesis and structures of nickel and palladium salicylaldiminato 1,3,5-triaza-7-phosphaadamantane (PTA) complexes
    Darensbourg, DJ
    Ortiz, CG
    Yarbrough, JC
    [J]. INORGANIC CHEMISTRY, 2003, 42 (21) : 6915 - 6922
  • [4] Borane adducts of the water soluble phosphine PTA (PTA=1,3,5-triaza-7-phosphaadamantane)
    Bolaño, S
    Albinati, A
    Bravo, J
    Gonsalvi, L
    Peruzzini, M
    [J]. INORGANIC CHEMISTRY COMMUNICATIONS, 2006, 9 (04) : 360 - 363
  • [5] Intramolecular hydroamination of alkynylamines in aqueous media catalyzed by platinum(II) 1,3,5-triaza-7-phosphaadamantane (PTA) complexes
    Krogstad, DA
    Owens, SB
    Halfen, JA
    Young, VG
    [J]. INORGANIC CHEMISTRY COMMUNICATIONS, 2005, 8 (01) : 65 - 69
  • [6] Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs
    Garcia-Moreno, Elena
    Gascon, Sonia
    Atrian-Blasco, Elena
    Jesus Rodriguez-Yoldi, Ma
    Cerrada, Elena
    Laguna, Mariano
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 79 : 164 - 172
  • [7] 1,3,5-triaza-7-phosphaadamantane (PTA): A practical and versatile nucleophilic phosphine organocatalyst
    Tang, Xiaofang
    Zhang, Bo
    He, Zhengrong
    Gao, Ruili
    He, Zhengjie
    [J]. ADVANCED SYNTHESIS & CATALYSIS, 2007, 349 (11-12) : 2007 - 2017
  • [8] Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (II) carboxylates
    Sguizzato, Maddalena
    Cortesi, Rita
    Gallerani, Eleonora
    Drechsler, Markus
    Marvelli, Lorenza
    Mariani, Paolo
    Carducci, Federica
    Gavioli, Riccardo
    Esposito, Elisabetta
    Bergamini, Paola
    [J]. MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 74 : 357 - 364
  • [9] Thermal and photochemical reactivity of tetraamineruthenium complexes containing 1,3,5-triaza-7-phosphaadamantane as a ligand
    Frugeri, PM
    Vasconcellos, LCG
    Mazzetto, SE
    Franco, DW
    [J]. NEW JOURNAL OF CHEMISTRY, 1997, 21 (03) : 349 - 354
  • [10] Ruthenium Complexes Containing 2,2′-Bipyridine and 1,3,5-Triaza-7-phosphaadamantane
    Scalambra, Franco
    Serrano-Ruiz, Manuel
    Nahim-Granados, Samira
    Romerosa, Antonio
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2016, (10) : 1528 - 1540